Lapitan, Bernadine .

HRN: 28-17-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2025
CEFUROXIME 1.5GM (VIAL)
12/11/2025
12/18/2025
IV
1.5g
Q8h
STAT CS
Checking Final Appropriateness 
12/11/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/11/2025
12/14/2025
IV
500mg
Q8h
S/P CS
Checking Final Appropriateness 
12/13/2025
CEFUROXIME 500MG (TAB)
12/13/2025
12/20/2025
PO
500mg
BID
S/P LTCS W/ IUD
Checking Final Appropriateness 
12/13/2025
METRONIDAZOLE 500MG (TAB)
12/13/2025
12/20/2025
PO
500mg
TID
S/P LTCS W/ IUD
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: